Related by context. All words. (Click for frequent words.) 74 CYPHER ® Stent 72 mm Stent 72 sirolimus eluting stent 72 paclitaxel eluting stents 72 TAXUS Express Stent 71 Cypher Stent 71 TAXUS stent 70 CYPHER R Stent 70 sirolimus eluting stents 70 CYPHER Stent 70 binary restenosis 70 diameter stenosis 69 XIENCE V PROMUS Stent 69 sirolimus eluting 69 everolimus eluting stent 69 sirolimus stent 68 CYPHER R Sirolimus eluting 68 TAXUS Stent 68 TAXUS Liberte Long 68 endarterectomy 68 target lesion revascularization 68 nondiabetic patients 67 workhorse lesions 67 TAXUS Liberte Stent 67 radical nephrectomy 67 tirofiban 67 XIENCE V demonstrated 67 CYPHER ® 67 definite stent thrombosis 67 multivessel disease 67 FOLFOX4 66 angiographic outcomes 66 TAXUS 66 bivalirudin monotherapy 66 repeat revascularization 66 TAXUS p value 66 OPCAB 66 Stenting 66 Angiographic 66 reinfarction 66 everolimus eluting stents 66 Coronary Stent 66 MACCE 66 mcg QD 66 abciximab 66 unfractionated heparin 66 IFN alfa 66 stent DES 66 TAXUS Element Stent 66 active comparator 66 XIENCE V stent 65 PROMUS 65 noninferior 65 revascularizations 65 perioperative mortality 65 TAXUS ® 65 placebo dexamethasone 65 stent restenosis 65 primary patency 65 paclitaxel eluting stent 65 TAXUS Express 65 chemoembolization 65 radial artery grafts 65 transthoracic 65 carotid endarterectomy 65 percutaneous intervention 65 Patency 65 iodixanol 65 NEVO 65 Doxil ® 65 NEVO ™ 65 ARCOXIA 65 bivalirudin 65 CIMZIA ™ 65 zotarolimus eluting stent 64 unfractionated heparin UFH 64 ticagrelor 64 carotid endarterectomy CEA 64 transfemoral 64 SYNTAX 64 lopinavir r arm 64 eptifibatide 64 enoxaparin 64 reintervention 64 Stent System 64 ARB telmisartan 64 NSTE ACS 64 saphenous vein grafts 64 oral diclofenac 64 Stenting Trial CREST 64 zotarolimus 64 Events MACE 64 patients undergoing CABG 64 uncoated stent 64 eplerenone 64 plain radiographs 64 stable angina 64 coronary intervention 64 GP IIb IIIa inhibitors 64 SYNTAX trial 64 stage IIIb IV 63 oncologic outcomes 63 preintervention 63 events MACE 63 tamsulosin 63 Target Lesion Revascularization TLR 63 Bivalirudin 63 stenoses 63 TAXUS Liberté stent 63 TAXUS Liberte Atom Stent 63 KRAS mutations occur 63 dalteparin 63 lymphadenectomy 63 XIENCE V vs. 63 receiving prophylactic anticoagulation 63 HoLEP 63 primary percutaneous coronary 63 angioplasty stenting 63 stenting 63 carotid artery stenting 63 undergoing coronary artery 63 nephron sparing surgery 63 non valvular atrial 63 Hazard Ratio 63 thromboembolic events 63 chlorambucil 63 TAXUS Express2 63 Stent thrombosis 63 ATACAND 63 advanced adenomas 63 periprocedural 63 conventional angiography 63 elective PCI 63 aldosterone antagonist 63 CABG surgeries 63 TAXUS R 63 plus GP IIb 63 transurethral resection 63 nicardipine 63 oxycodone CR 63 bypass graft CABG surgery 63 colorectal liver metastases 63 Percutaneous Coronary Intervention 63 patients undergoing percutaneous 63 carotid artery stenting CAS 63 postintervention 63 mg BID dose 62 percutaneous transluminal coronary angioplasty 62 stent implantation 62 ischemia driven 62 FOLFIRI 62 plus prednisone 62 Atom Stent 62 Genous stent 62 p = NS 62 HORIZONS AMI trial 62 fondaparinux 62 revascularization procedures 62 paclitaxel eluting 62 TAXUS Liberté 62 Sirolimus eluting Coronary Stent 62 aspirin heparin 62 cilostazol 62 dual antiplatelet therapy 62 Operative mortality 62 revascularization 62 nonobstructive CAD 62 candesartan cilexetil 62 CANCIDAS 62 morphometric vertebral fractures 62 CYPHER R Sirolimus Eluting 62 endophthalmitis 62 stent thromboses 62 coronary interventions 62 paclitaxel stent 62 retropubic 62 chemoradiation therapy 62 cholecystectomy 62 Prospective Randomized Trial 62 low dose Iluvien 62 IIIa inhibitors 62 plus glycoprotein IIb 62 PROMUS Element Stent 62 insulin detemir 62 NATRECOR ® 62 penetrating keratoplasty 62 #.#mg/dL 62 irbesartan 62 paroxysmal AF 62 DES implantation 62 ACUITY trial 62 Bare Metal Stents 62 nonfatal MI 62 arterial thromboembolic events 62 SYNERGY Stent 62 Thrombolysis 62 LVEF 62 lumbar spine BMD 62 Sirolimus eluting 62 nonoperative 62 trabeculectomy 62 symptomatic carotid stenosis 62 infliximab monotherapy 62 NAVISTAR R 62 thromboembolism 62 cytoreductive surgery 62 stented 62 comparator arm 62 STEMI patients 62 XIENCE V Everolimus Eluting 62 restenotic lesions 62 XELOX 62 ACTEMRA TM 62 nonrandomized 62 CABG 62 carboplatin paclitaxel 62 lopinavir r 62 TAVR 61 bypass grafts 61 coronary artery bypass grafting 61 unstable angina pectoris 61 β blockers 61 carotid intima media 61 deep venous thromboses 61 methotrexate monotherapy 61 recurrent GBM 61 MitraClip device 61 endovascular repair 61 GORE VIABAHN Endoprosthesis 61 Folfox 61 Zometa hazard 61 TURP 61 pegylated liposomal doxorubicin 61 intravesical therapy 61 FOLFOX 61 subtrochanteric 61 postoperative morbidity 61 LV dysfunction 61 Resolute DES 61 FOLFOX4 alone 61 tapentadol ER 61 oxycodone IR 61 intracoronary 61 pegylated interferon alfa 2b 61 mg QD 61 tiotropium 61 TAXUS TM 61 tolvaptan 61 CABG surgery 61 splenectomized 61 anti arrhythmic drug 61 ARIXTRA 61 rFVIIa 61 embolizations 61 EBRT 61 thrombus aspiration 61 ischemic cardiomyopathy 61 stenting procedures 61 pCR 61 thromboembolic complications 61 ezetimibe simvastatin 61 ® Liberte 61 coronary lesions 61 INTEGRILIN R 61 TAXUS ATLAS 61 TACE 61 target vessel revascularization 61 left ventricular dysfunction 61 TAXUS Liberte 61 aspirin clopidogrel 61 -#.# mg dL [001] 61 treated nonsurgically 61 Coronary Artery Bypass Graft 61 postoperative chemotherapy 61 RE LY ® 61 coronary stenosis 61 RYGB 61 TAXUS Express Atom Stent 61 rosuvastatin #mg 61 pneumonectomy 61 noninferiority 61 left ventricular systolic 61 NMIBC 61 perioperative complications 61 coronary revascularization 60 Sirolimus Eluting Coronary Stent 60 Drug eluting stent 60 radical cystectomy 60 fibrinolytic therapy 60 candesartan 60 Myocardial Infarction Study 60 carotid stenosis 60 oral allopurinol 60 analgesic efficacy 60 Severity MSCS score 60 NEVO TM 60 Index CDAI 60 prospective randomized controlled 60 PROMUS ® 60 DAPT 60 bypass grafting 60 plus dexamethasone 60 rebleeding 60 hip BMD 60 HBeAg seroconversion 60 CYPHER ® Sirolimus eluting 60 clodronate 60 FOLPI 60 MULTI LINK VISION 60 titrated glipizide 60 rosuvastatin 60 revascularisation 60 nonfatal myocardial infarction 60 atheroma volume 60 postoperative complication 60 Pharmacokinetic parameters 60 Coronary Stent System 60 antiarrhythmic drug 60 Endeavor Resolute 60 angiographic restenosis 60 Express2 TM paclitaxel eluting 60 RE LY 60 abacavir lamivudine 60 Kaplan Meier analysis 60 Carotid Revascularization Endarterectomy vs. 60 aldosterone antagonists 60 quantitative coronary angiography 60 5-FU/LV 60 biochemical recurrence 60 percutaneous coronary intervention 60 posterolateral fusion 60 HBeAg negative patients 60 SPIRIT III 60 liver resection 60 cardiac resynchronisation therapy 60 drotrecogin alfa activated 60 stent binary restenosis 60 FFR guided treatment 60 TAVI 60 atorvastatin #mg 60 Heparin Bioactive Surface 60 cinacalcet 60 TRITON TIMI 60 TAXUS V 60 postoperative mortality 60 Enoxaparin 60 symptomatic VTE 60 XIENCE V 60 achieved statistical significance 60 ipsilateral stroke 60 sunitinib Sutent 60 hemodynamically significant 60 sustained virological response 60 ST elevation myocardial 60 intravascular ultrasound 60 glycoprotein IIb IIIa inhibitors 60 preoperative chemotherapy 60 non squamous NSCLC 60 TLIF 60 advanced adenoma 60 carotid stenting 60 #mg BID [001] 60 lispro 60 wedge resection 60 β blocker 60 Coronary artery bypass grafting 60 invasive coronary angiography 60 non inferiority 60 TAXUS Express2 Paclitaxel Eluting 60 vertebral fracture 60 underwent CABG 60 prostate TURP 60 hepatic resection 60 gemcitabine Gemzar 60 peginterferon alfa 2a 60 tenecteplase 60 Bare Metal Stent 60 mcg BID 60 stent BMS 60 TAXUS stents 60 severe neutropenia 60 coronary stenting 60 clopidogrel Plavix 60 X ray angiography 60 ICD implantation 60 Long Lesion 60 VATS lobectomy 59 neoadjuvant 59 ePTFE graft 59 neoadjuvant therapy 59 ximelagatran 59 Acute Myocardial Infarction 59 octreotide LAR 59 mcg albinterferon alfa 2b 59 esophagectomy 59 fluvastatin 59 de novo lesions 59 mycophenolate mofetil 59 carboplatin chemotherapy 59 GORE TAG Device 59 NNT = 59 thrombotic events 59 undetectable HBV DNA 59 statistically significant p = 59 cisplatin vinorelbine 59 Resolute drug eluting 59 Cordis Cypher 59 drug eluting stent implantation 59 luminal diameter 59 gadobutrol 59 P = .# 59 dacarbazine 59 sorafenib Nexavar 59 Nitinol Stent 59 TAXUS Liberte stent 59 Pain Intensity 59 FFR guided 59 IIIa inhibitor 59 VTE prophylaxis 59 reoperation 59 Acute Coronary Syndromes 59 myocardial infarction stroke 59 endothelial keratoplasty 59 imipenem 59 locoregional recurrence 59 Complication rates 59 ST Elevation Myocardial 59 hepatectomy 59 nodal metastases 59 teriparatide 59 infarction STEMI 59 graft patency 59 ARCALYST ® 59 colorectal adenoma 59 SLNB 59 valsartan 59 angiographic 59 undergone radical prostatectomy 59 lipid lowering therapy 59 intraobserver 59 revascularization procedure 59 myocardial infarction MI 59 biphasic insulin aspart 59 certolizumab 59 colectomy 59 Endeavor drug eluting 59 intravitreal injections 59 Anti Bacterial Envelope 59 CRESTOR #mg 59 transarterial 59 ALND 59 ReoPro 59 leiomyomas 59 parathyroidectomy 59 alteplase 59 Micardis ® 59 Ejection Fraction 59 intima media thickness 59 coronary angiography 59 alfuzosin 59 serum urate 59 PressureWire 59 weekly CSBMs 59 composite endpoint 59 pain palliation 59 Intracranial 59 tapentadol IR 59 IOP lowering 59 Hazard Ratio HR 59 surgical revascularization 59 PREZISTA r 59 dimensional computed tomography 59 MoxDuo TM IR 59 incisional 59 perioperative morbidity 59 thromboprophylaxis 59 carotid artery stenosis 59 retinal vein occlusion 59 recurrent VTE 59 superficial femoral 59 clopidogrel Plavix ® 59 infarct size 59 mg TID 59 ketorolac 59 Clinical Outcomes Utilizing Revascularization 59 tolterodine ER 59 NATRECOR R 59 DOXIL 59 HES CEL 59 ACR# response 59 SPIRIT FIRST 59 NPH insulin 59 xanthine oxidase inhibitor 59 drug eluting coronary stents 59 uncoated stents 59 autologous chondrocyte implantation 59 eluting stents 59 Endarterectomy 59 mg ustekinumab 59 micafungin 59 elevated IOP 59 DMARD 59 patency 59 FluCAM arm 59 GP IIb IIIa inhibitor 59 adjuvant radiation 59 pioglitazone 59 MitraClip 59 drug eluting stents 58 refractory ischemia 58 EUS FNA 58 standard chemotherapy regimen 58 hemoglobin A1c levels 58 Endeavor stent 58 bezafibrate 58 platinum chromium alloy 58 BENICAR HCT 58 dose clopidogrel 58 renal artery stenting 58 achieved ACR# 58 EURIDIS 58 interferon alfa 2b 58 intravascular ultrasound IVUS 58 percutaneous coronary interventions 58 CCyR 58 venous thromboembolism 58 Pioglitazone 58 oral antidiabetic medication 58 percutaneous vertebroplasty 58 invasive candidiasis 58 occlusive disease 58 8mg/kg 58 V Everolimus Eluting Coronary 58 thoracoscopic lobectomy 58 transesophageal echocardiography 58 extracranial 58 CYPHER R stent 58 pulmonary artery banding 58 Dabigatran 58 posaconazole 58 EuroSCORE 58 transurethral 58 interferon ribavirin 58 colposuspension 58 bi ventricular pacing 58 asymptomatic carotid stenosis 58 #mg BID [003] 58 REYATAZ r arm 58 Protelos 58 MSCT 58 ACR# responses 58 postoperative radiographs 58 Ranolazine 58 endoleaks 58 thrombolytic therapy 58 receiving VICTRELIS 58 placebo p 58 salmeterol fluticasone 58 nephrectomy 58 stent stenosis 58 acute myocardial infarction AMI 58 -#.# log# 58 clinically localized prostate 58 Endoprosthesis 58 FDG-PET/CT 58 total hip arthroplasties 58 dose atorvastatin 58 PSA nadir 58 LEXIVA r 58 interobserver reliability 58 Capecitabine 58 mL/min/#.# m 2 58 arteriography 58 platelet inhibitor 58 dimensional echocardiography 58 IM progesterone 58 conventional coronary angiography 58 metastatic GIST 58 Montgomery Asberg Depression 58 idraparinux 58 Abbott bioabsorbable everolimus eluting 58 Coronary artery bypass graft 58 Cypher Sirolimus 58 Balloon Kyphoplasty 58 CIMZIA TM certolizumab pegol 58 acute coronary syndromes 58 TAXUS Express2 paclitaxel eluting 58 interferon alfa 2a 58 dabigatran etexilate 58 esomeprazole 58 TORISEL 58 doxazosin 58 benazepril 58 PROMUS Element Everolimus Eluting 58 Free Survival PFS 58 nonoperative treatment 58 neointimal 58 vinorelbine 58 Fludara 58 #Gy 58 coronary vessels 58 NSTEMI 58 ST Segment Elevation 58 defibrillator CRT D 58 acute coronary syndromes ACS 58 CC genotype 58 uncorrected visual acuity 58 WallFlex Biliary RX 58 SUVmax 58 angiographically 58 transcatheter aortic valve implantation 58 Hycamtin ® 58 ExTRACT TIMI 58 Major Adverse Cardiac 58 debulking surgery 58 axillary lymph node dissection 58 rizatriptan 58 RECORD1 58 atherothrombotic disease 58 peginterferon alfa 2a #KD 58 angiotensin receptor blocker ARB 58 functional mitral regurgitation 58 ENDEAVOR IV 58 R# #mg BID 58 hepatic metastases 58 teriflunomide 58 Pegylated Liposomal Doxorubicin 58 STRIDE PD 58 amoxicillin clavulanate 58 plus methotrexate 58 Navelbine 58 TAXUS VI 58 metastatic neuroendocrine tumors 58 failure ADHF 58 serum phosphorous 58 RECIST Response Evaluation Criteria 58 creatinine clearance 58 lung metastases 58 restenosis 58 Export Aspiration Catheter 58 nesiritide 58 APTIVUS r 58 glycated hemoglobin levels 58 nonvertebral 58 renal tumors 58 THERMOCOOL R 58 carotid angioplasty 58 femoral shaft fractures 58 sleeve lobectomy 58 VELCADE melphalan 58 placebo p = 58 thromboembolic 58 clopidogrel 58 resected pancreatic cancer 58 ABVD 58 invasive angiography 58 Burch colposuspension 58 peginterferon alfa 2b 58 pump CABG 58 drug eluting stent 58 lobectomy 58 death reinfarction 58 Fractional Flow Reserve 58 FOLFOX6 58 beta blocker atenolol 58 hemorrhagic complications 58 biochemical relapse 58 hemodialysis patients 58 adalimumab 58 dose pravastatin 58 unresectable HCC 58 thickness CIMT 58 PROMUS Element 58 underwent resection 58 cardiopulmonary bypass CPB 58 adenoma recurrence 58 HbA1c levels 58 lumbar spine bone 58 SVR# 58 F FDG PET 58 tumor lysis syndrome 58 crossclamp 58 colon capsule endoscopy 58 glomerular filtration 58 mitral insufficiency 58 leukocyte count 58 paricalcitol 58 R Paclitaxel Eluting 58 adenomatous 58 lumen diameter 58 prospective multicenter 58 PEGINTRON TM 58 4mg/kg 58 failure TVF 58 relapsed SCLC 58 -#.# ± [002] 58 #.#/#.# mmHg [001] 58 nonvertebral fracture 58 Stent Thrombosis 58 nadolol 58 prospectively stratified 58 CR nPR 58 Drug Eluting Stents 58 Baseline characteristics 58 femoral neck BMD 58 tacrolimus ointment 58 total thyroidectomy 58 stents BMS 58 Oral Fingolimod 58 strontium ranelate 58 ABSORB trial 58 SGRQ 58 postmenopausal osteoporotic women 58 Prospective Randomized 58 balloon valvuloplasty 58 fundoplication 58 Pemetrexed 58 daunorubicin 58 PRADAXA 58 binary restenosis rate 57 unstable angina UA 57 tipranavir r 57 CI #.#-#.# [002] 57 Paclitaxel eluting 57 reoperations 57 ABC/3TC 57 oral rivaroxaban 57 PRECiSE 57 Xelox 57 pamidronate 57 mg clopidogrel 57 5 Fluorouracil 57 reinterventions 57 systemic embolism 57 contrast induced nephropathy 57 ULORIC 57 degenerative spondylolisthesis 57 PASI scores 57 MMSE scores 57 clinicopathological features 57 median PFS 57 CI #.#-#.# [001] 57 Breast conserving 57 Intracranial Aneurysms 57 epicardial 57 landmark ATHENA trial 57 #mg doses [002] 57 infrapopliteal 57 Castration Resistant Prostate Cancer 57 Postoperative 57 virologic response 57 gadolinium enhanced 57 Restenosis 57 melphalan prednisone 57 Randomized Evaluation 57 pulmonary angiography 57 coronary artery bypass grafts 57 glimepiride 57 liver transplant recipients 57 microbiological eradication 57 gauge vitrectomy 57 adjunctive placebo 57 chemotherapy gemcitabine 57 silent ischemia 57 dosage regimens 57 interobserver 57 preoperatively 57 Vascular Wrap 57 intracranial atherosclerosis 57 XGEVA 57 SORT OUT III 57 levosimendan 57 Computed tomography 57 pericardial effusion 57 urate lowering therapy 57 atrioventricular valve 57 chemoradiotherapy 57 mediated dilation 57 EBUS 57 multicentre randomized 57 neointimal hyperplasia 57 deep venous thrombosis 57 5 FU leucovorin 57 transabdominal 57 VaD 57 ALVESCO 57 PREZISTA ritonavir 57 metastatic RCC 57 Abciximab 57 lanthanum carbonate 57 dacarbazine chemotherapy 57 Acute Ischemic Stroke 57 albumin excretion rate 57 Cystectomy 57 lipid lowering agents 57 randomized multicenter trial 57 trabectedin 57 vertebral compression fractures 57 acute coronary syndrome 57 dose cytarabine 57 oral anticoagulation 57 arterial grafts 57 myocardial perfusion imaging 57 extra articular 57 x ray angiography 57 secondary efficacy endpoint 57 artery stenosis 57 ID TLR 57 lamivudine monotherapy 57 partial nephrectomy 57 mitomycin C 57 RVOT 57 abdominal hysterectomy 57 pT3 57 Amrubicin 57 liposome injection 57 ritonavir boosted 57 TURBT 57 Q2W 57 total hip arthroplasty 57 troponin T 57 BoNTA 57 liposomal doxorubicin 57 irinotecan cisplatin 57 bosentan 57 thinner struts 57 renal artery stenosis 57 Pivotal Trial 57 myocardial viability 57 underwent surgical resection 57 NHANES III 57 deferoxamine 57 urodynamic 57 prospective multicenter randomized 57 IPSS 57 undergoing coronary angiography 57 COPAXONE R 57 oral FTY# 57 TEAEs 57 confidence intervals CIs 57 COR Analyzer 57 plus gemcitabine 57 recurrent ischemia 57 #mmHg [001] 57 baseline HbA1c 57 PROMUS TM 57 Median survival 57 Candesartan 57 CORDAPTIVE 57 transcatheter closure 57 EVEREST II 57 coronary artery bypass graft 57 ablative therapy 57 simvastatin ezetimibe 57 mediastinitis 57 placebo fluoxetine 57 colesevelam HCl 57 radiotherapy RT 57 PCWP 57 ejection fractions 57 revascularized 57 colonography 57 zonisamide SR 57 Prograf ® 57 T1 weighted images 57 coronary stent merged 57 decitabine 57 preserved systolic 57 GPIIb IIIa inhibitors 57 nonvertebral fractures 57 eluting coronary stent 57 PICSO ® 57 platelet inhibition 57 stage IIIB 57 mCi kg 57 free survival PFS 57 rt PA 57 EBUS FNA 57 Amiodarone 57 PSADT 57 pT2 57 Pred Forte 57 intraocular inflammation 57 angiotensin converting enzyme inhibitor 57 CDAI score 57 Randomized Study 57 COMBIVIR 57 unresectable tumors 57 NYHA Class II 57 dronedarone 57 HOMA IR 57 metastatic HRPC 57 J Am Coll 57 graft occlusion 57 vitrectomy 57 myocardial reperfusion 57 ™ Everolimus Eluting 57 pantoprazole 57 recurrent DVT 57 locoregional 57 undergoing percutaneous coronary 57 Renal Artery 57 segmentectomy 57 Combo Stent 57 randomized controlled clinical trials 57 adenoidectomy 57 periprocedural MI 57 steroid dexamethasone 57 intraoperatively 57 splenectomized patients 57 invasive aspergillosis 57 phakic 57 myocardial ischemia 57 rs# [002] 57 interobserver agreement 57 STEMI ST 57 Crohn Disease Activity 57 Median PFS 57 HbA 1c levels 57 desvenlafaxine succinate 57 gemcitabine carboplatin 57 Tolerability 57 myocardial infarctions 57 myocardial infarction 57 DEFINITY ® 57 liposomal amphotericin B 57 surgical aortic valve 57 total knee arthroplasties 57 Stenting Trial 57 plus MTX 57 Eluting Coronary Stent System 57 radial artery 57 azacitidine 57 Guideline Update 57 TKAs 57 beta blocker therapy 57 p = .# [001] 57 transapical 57 stent grafts 57 ACE inhibitor ramipril 57 aplastic anemia AA 57 nodular partial response 57 Controlled Trial 57 aortic insufficiency 57 pimecrolimus 57 duplex ultrasonography 57 mg qd 57 gadolinium enhancing lesions 57 CsA 57 drug eluting coronary stent 57 Betaferon ® 57 external beam radiotherapy 57 MADRS score 57 radical retropubic prostatectomy 57 ß blockers 57 artificial arteriovenous dialysis 57 carotid artery stent 57 laparoscopic cholecystectomy 57 bivalirudin alone 57 TAXUS Element 57 Paclitaxel Eluting Coronary Stent 57 pulsatile flow 56 p = #.# [003] 56 LAGB 56 prospectively randomized 56 ribavirin RBV 56 ICDs implanted 56 dose dexamethasone 56 Non inferiority 56 oral Hycamtin 56 Peg IFN 56 stent thrombosis 56 nonfatal myocardial infarction MI 56 Randomized Clinical Trial 56 dacarbazine DTIC 56 intravenous diuretics 56 RE LY trial 56 CABG coronary artery 56 PegIntron 56 treated nonoperatively 56 hsCRP levels 56 Endeavor Drug Eluting 56 doripenem 56 radiochemotherapy 56 Self Expanding Stent 56 Everolimus Eluting Coronary Stent 56 annualized relapse 56 PRADAXA #mg 56 Rivaroxaban 56 fraction LVEF 56 RARP 56 q8h 56 fluticasone salmeterol 56 GnRH agonists 56 Aggressive Drug Evaluation 56 CLINICAL STUDIES 56 chlorthalidone 56 prespecified secondary 56 vertebral fractures